With pressure from global competitors and recent changes in domestic policy threatening to undermine U.S. leadership in this ...

Mosaic expects the collaboration with the FDA will help address diagnostic capacity constraints in the US healthcare system.

Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI ...

As a physician who has spent decades caring for patients and later had the privilege of serving as Secretary of Health and Human Services, I have seen firsthand how fragile medical progress can be.

The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.

Lonial emphasizes that the EXCALIBER-RRMM trial is a test case for a new regulatory framework. The study utilizes dual primary end points to satisfy both accelerated and full approval requirements: ...

Innovation is one of the most celebrated yet misunderstood ideas of our time. It is invoked in policy speeches, corporate ...

Robert F. Kennedy Jr. announced the commitments in Washington, even as some in the medical community questioned whether the government should try to influence curriculums.

Recent developments in the healthcare sector include WHO's confirmation of attacks on healthcare facilities in Iran, a promising trial for Regenxbio's Duchenne gene therapy, Eli Lilly's investment in ...

Natus Medical Incorporated has announced the global launch of the autoSCORE analysis tool, spreading the availability of the first artificial-intelligence ...

Artificial intelligence is rapidly transforming the life sciences industry, particularly in areas where speed and precision can dramatically impact research outcomes. From drug discovery to clinical ...

Colorado is pioneering future industries, from FDA-approved AI in prenatal care to crafting the Orion spacecraft for lunar missions.